380 related articles for article (PubMed ID: 18096083)
1. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
Christo PP; Greco DB; Aleixo AW; Livramento JA
BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 RNA levels in cerebrospinal fluid and plasma and their correlation with opportunistic neurological diseases in a Brazilian AIDS reference hospital.
Christo PP; Greco DB; Aleixo AW; Livramento JA
Arq Neuropsiquiatr; 2005 Dec; 63(4):907-13. PubMed ID: 16400403
[TBL] [Abstract][Full Text] [Related]
3. Analysis of correlation between cerebrospinal fluid and plasma HIV-1 RNA levels in patients with neurological opportunistic diseases.
Christo PP; Greco DB; Aleixo AW; Livramento JA
Rev Inst Med Trop Sao Paulo; 2011; 53(4):193-6. PubMed ID: 21915461
[TBL] [Abstract][Full Text] [Related]
4. Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration.
Eggers C; Hertogs K; Stürenburg HJ; van Lunzen J; Stellbrink HJ
AIDS; 2003 Sep; 17(13):1897-906. PubMed ID: 12960822
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system.
Christo PP; Vilela Mde C; Bretas TL; Domingues RB; Greco DB; Livramento JA; Teixeira AL
J Neurol Sci; 2009 Dec; 287(1-2):79-83. PubMed ID: 19782379
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system.
Gallo P; Sivieri S; Rinaldi L; Yan XB; Lolli F; De Rossi A; Tavolato B
J Neurol Sci; 1994 Oct; 126(1):49-53. PubMed ID: 7836946
[TBL] [Abstract][Full Text] [Related]
7. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis.
Cinque P; Vago L; Ceresa D; Mainini F; Terreni MR; Vagani A; Torri W; Bossolasco S; Lazzarin A
AIDS; 1998 Mar; 12(4):389-94. PubMed ID: 9520168
[TBL] [Abstract][Full Text] [Related]
10. HIV-1C
Kelentse N; Moyo S; Mogwele ML; Ditshwanelo D; Mokaleng B; Moraka NO; Lechiile K; Leeme TB; Lawrence DS; Musonda R; Kasvosve I; Harrison TS; Jarvis JN; Gaseitsiwe S
Viruses; 2020 Dec; 12(12):. PubMed ID: 33297399
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.
Arendt G; Nolting T; Frisch C; Husstedt IW; Gregor N; Koutsilieri E; Maschke M; Angerer A; Obermann M; Neuen-Jacob E; Adams O; Loeffert S; Riederer P; ter Meulen V; Sopper S;
J Neurovirol; 2007 Jun; 13(3):225-32. PubMed ID: 17613712
[TBL] [Abstract][Full Text] [Related]
13. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
Matinella A; Lanzafame M; Bonometti MA; Gajofatto A; Concia E; Vento S; Monaco S; Ferrari S
J Neurol; 2015 May; 262(5):1317-27. PubMed ID: 25877836
[TBL] [Abstract][Full Text] [Related]
14. Detection of HIV RNA levels in intraocular and cerebrospinal fluids in patients with AIDS-related cryptococcosis.
Peng CH; Chen SJ; Ho CK; Ku HH; Lin HW; Chen SS; Wu CC; Chi CW; Hsu WM; Chiou SH
Ophthalmologica; 2005; 219(2):101-6. PubMed ID: 15802935
[TBL] [Abstract][Full Text] [Related]
15. A Comparative Study of CSF Viral RNA Loads between HIV Positive Patients with Neurological Manifestations and Neurologically Asymptomatic HIV Patients.
Mathur AD; Devesh S
J Assoc Physicians India; 2017 Aug; 65(8):14-17. PubMed ID: 28799299
[TBL] [Abstract][Full Text] [Related]
16. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients.
Antinori A; Giancola ML; Grisetti S; Soldani F; Alba L; Liuzzi G; Amendola A; Capobianchi M; Tozzi V; Perno CF
AIDS; 2002 Sep; 16(14):1867-76. PubMed ID: 12351946
[TBL] [Abstract][Full Text] [Related]
18. Clinical factors related to brain structure in HIV: the CHARTER study.
Jernigan TL; Archibald SL; Fennema-Notestine C; Taylor MJ; Theilmann RJ; Julaton MD; Notestine RJ; Wolfson T; Letendre SL; Ellis RJ; Heaton RK; Gamst AC; Franklin DR; Clifford DB; Collier AC; Gelman BB; Marra C; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I;
J Neurovirol; 2011 Jun; 17(3):248-57. PubMed ID: 21544705
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees C.
Ahmad M; Tashima KT; Caliendo AM; Flanigan TP
AIDS; 1999 Jul; 13(10):1281-2. PubMed ID: 10416538
[No Abstract] [Full Text] [Related]
20. Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana.
Kelentse N; Moyo S; Mogwele M; Lechiile K; Moraka NO; Maruapula D; Seatla KK; Esele L; Molebatsi K; Leeme TB; Lawrence DS; Musonda R; Kasvosve I; Harrison TS; Jarvis JN; Gaseitsiwe S
Medicine (Baltimore); 2020 Oct; 99(41):e22606. PubMed ID: 33031315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
